To explore the clinical efficacy and complications of vacuum-assisted minimally invasive breast gyrotomy in the treatment of mammary fibroma.

The clinical data of 105 patients with breast fibroma from January 2021 to October 2023 were retrospectively analyzed and divided into observation group (vacuum-assisted minimally invasive breast gyrotomy,n=55) and control group (circumareolar incision, n=50) according to different surgical methods. Statistical software SPSS 22.0 was used for analysis. Perioperative clinical indicators, scar scale (VSS) and other measurement data were presented with (). Independent sample t test was used. The incidence of postoperative complications and the recovery of sensory nerve function in areola were measured by χ² test. P<0.05 indicated that the difference was statistically significant.

The operative time, intraoperative blood loss, incision healing time and incision length in observation group were significantly lower than those in control group (P<0.05). One week after surgery, the incidence of postoperative complications in observation group (1.8%) was significantly lower than that in control group (14.0%) (P<0.05). At 1 week, 1 month and 3 months after operation, the VSS score of observation group was significantly lower than that of control group (P<0.05). At 3 months after operation, the normal rate of sensory nerve function in the areolar region in observation group was significantly higher than that in control group (P<0.05).

Vacuum-assisted minimally invasive breast gyrotomy for the treatment of breast fibroma not only reduces postoperative complications, but also accelerates scar healing and the recovery of sensory nerve function in areola region.